Income Taxes	9 Months Ended
Income Taxes	Jun. 26, 2020
Income Tax Disclosure [Abstract]
Income Taxes	8. INCOME TAXES On March 27, 2020, President Trump signed into U.S. federal law the CARES Act, which is aimed at providing emergency assistance and health care for individuals, families, and businesses affected by the COVID-19 pandemic and generally supporting the U.S. economy. The CARES Act, among other things, includes provisions related to refundable payroll tax credits, deferment of the employer portion of social security payments, net operating loss carryback periods, modifications to the net interest deduction limitations, and technical corrections to tax depreciation methods for qualified improvement property. At this time, we do not expect there to be a material impact to our condensed consolidated financial statements as a result of this legislation. For the three months ended June 26, 2020 and June 28, 2019, the Company's effective tax rate attributable to income before income taxes was 26.5% and 23.3%, respectively. For the three months ended June 26, 2020 and June 28, 2019, the Company's income tax expense was $8,672 and $11,106 respectively. The increase in the current period effective tax rate was primarily due to an increase in losses incurred by our foreign jurisdictions for which we are not able to realize the related tax benefit. For the nine months ended June 26, 2020 and June 28, 2019, the Company's effective tax rate attributable to income before income taxes was 22.9% and 24.1%, respectively. For the nine months ended June 26, 2020 and June 28, 2019, the Company's income tax expense was $29,112 and $29,513 respectively. The decrease in the current period effective tax rate was primarily due to an increase in the excess tax benefit associated with stock compensation, partially offset by the increase in losses incurred by our foreign jurisdictions for which we are not able to realize the related tax benefit. A valuation allowance has been recorded against certain net operating losses in certain foreign jurisdictions. A valuation allowance is recorded when it is determined to be more likely than not that these assets will not be fully realized in the foreseeable future. The realization of deferred tax assets is dependent upon whether the Company can generate future taxable income in the appropriate character and jurisdiction to utilize the assets. The amount of the deferred tax assets considered realizable is subject to adjustment in future periods. The Company recognizes the benefits of uncertain tax positions taken or expected to be taken in tax returns in the provision for income taxes only for those positions that we have determined are more likely than not to be realized upon examination. We record interest and penalties related to unrecognized tax benefits as a component of income tax expense. During the nine months ended June 26, 2020, the balance of unrecognized tax benefits decreased by $108 upon the resolution of a state audit item. For the nine months ended June 26, 2020, the Company made no additional provision for U.S. or non-U.S. income taxes for unrecognized deferred tax liabilities for temporary differences related to basis differences in investments in subsidiaries, as the investments are essentially permanent in duration.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.